Authors:
Bustami, R
Lesaffre, E
Molenberghs, G
Loos, R
Danckaerts, M
Vlietinck, R
Citation: R. Bustami et al., Modelling bivariate ordinal responses smoothly with examples from ophthalmology and genetics, STAT MED, 20(12), 2001, pp. 1825-1842
Authors:
Lesaffre, E
Bluhmki, E
Wang-Clow, F
Berioli, S
Danays, T
Fox, NL
Van de Werf, F
Citation: E. Lesaffre et al., The general concepts of an equivalence trial, applied to ASSENT-2, a large-scale mortality study comparing two fibrinolytic agents in acute myocardial infarction, EUR HEART J, 22(11), 2001, pp. 898-902
Citation: E. Lesaffre et B. Spiessens, On the effect of the number of quadrature points in a logistic random-effects model: an example, J ROY STA C, 50, 2001, pp. 325-335
Authors:
Barbash, GI
Birnbaum, Y
Bogaerts, K
Hudson, M
Lesaffre, E
Fu, YL
Goodman, S
Houbracken, K
Munsters, K
Granger, CB
Pieper, K
Califf, RM
Topol, EJ
Van de Werf, F
Citation: Gi. Barbash et al., Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction - An analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO I) and assessment of the safety of a new thrombolytic(ASSENT 2) studies, CIRCULATION, 103(7), 2001, pp. 954-960
Citation: E. Lesaffre et al., Assessing the goodness-of-fit of the Laird and Ware model - An example: The Jimma Infant Survival Differential Longitudinal Study, STAT MED, 18(7), 1999, pp. 835-854
Authors:
Buyse, M
George, SL
Evans, S
Geller, NL
Ranstam, J
Scherrer, B
Lesaffre, E
Murray, G
Edler, L
Hutton, J
Colton, T
Lachenbruch, P
Verma, BL
Citation: M. Buyse et al., The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials, STAT MED, 18(24), 1999, pp. 3435-3451
Authors:
Van de Werf, F
Adgey, J
Ardissino, D
Armstrong, PW
Aylward, P
Barbash, G
Betriu, A
Binbrek, AS
Califf, R
Diaz, R
Fanebust, R
Fox, K
Granger, C
Heikkila, J
Husted, S
Jansky, P
Langer, A
Lupi, E
Maseri, A
Meyer, J
Mlczoch, J
Mocceti, D
Myburgh, D
Oto, A
Paolasso, E
Pehrsson, K
Seabra-Gomes, R
Soares-Piegas, L
Sugrue, D
Tendera, M
Topol, E
Toutouzas, P
Vahanian, A
Verheugt, F
Wallentin, L
White, H
Berioli, S
Bluhmki, E
Brower, R
Danays, T
Fox, NL
Girault, C
Goetz, G
Houbracken, K
Jakob, H
Kaye, J
Sarelin, H
Clow, FW
Hacke, W
von Kummer, L
Lesaffre, E
Bluhmki, E
Bogaerts, K
Munster, K
Scheys, I
Truyen, M
Clow, FW
Fox, KAA
Brower, R
Hallstrom, A
Jones, D
Maggioni, A
Weaver, D
Citation: F. Van De Werf et al., Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial, LANCET, 354(9180), 1999, pp. 716-722
Authors:
Manelfe, C
Larrue, V
von Kummer, R
Bozzao, L
Ringleb, P
Bastianello, S
Iweins, F
Lesaffre, E
Citation: C. Manelfe et al., Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator, STROKE, 30(4), 1999, pp. 769-772
Authors:
Davalos, A
Toni, D
Iweins, F
Lesaffre, E
Bastianello, S
Castillo, J
Citation: A. Davalos et al., Neurological deterioration in acute ischemic stroke - Potential predictorsand associated factors in the European Cooperative Acute Stroke Study (ECASS) I, STROKE, 30(12), 1999, pp. 2631-2636
Authors:
Fiorelli, M
Bastianello, S
von Kummer, R
del Zoppo, GJ
Larrue, V
Lesaffre, E
Ringleb, AP
Lorenzano, S
Manelfe, C
Bozzao, L
Citation: M. Fiorelli et al., Hemorrhagic transformation within 36 hours of a cerebral infarct - Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort, STROKE, 30(11), 1999, pp. 2280-2284